Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma

Glenn J. Hanna; Vishwajith Sridharan; Danielle N. Margalit; Stephanie K. La Follette; Nicole G. Chau; Guilherme Rabinowits; Jochen H. Lorch; Robert I. Haddad; Roy B. Tishler; Karen S. Anderson; Jonathan D. Schoenfeld

doi:10.3233/CBM-160071

Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma

Glenn J. Hanna, Vishwajith Sridharan, Danielle N. Margalit, Stephanie K. La Follette, Nicole G. Chau, Guilherme Rabinowits, Jochen H. Lorch, Robert I. Haddad, Roy B. Tishler, Karen S. Anderson, Jonathan D. Schoenfeld

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Cancer Biomarkers
Volume	19
DOIs	https://doi.org/10.3233/CBM-160071
State	Published - Jun 23 2017
Externally published	Yes

Disciplines

Biology
Oncology

Access to Document

10.3233/CBM-160071License: Unspecified

Cite this

Hanna, G. J., Sridharan, V., Margalit, D. N., La Follette, S. K., Chau, N. G., Rabinowits, G., Lorch, J. H., Haddad, R. I., Tishler, R. B., Anderson, K. S., & Schoenfeld, J. D. (2017). Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma. Cancer Biomarkers, 19. https://doi.org/10.3233/CBM-160071

@article{403d0a816f894c8fb1a4c9fa1f3351e1,

title = "Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma",

author = "Hanna, \{Glenn J.\} and Vishwajith Sridharan and Margalit, \{Danielle N.\} and \{La Follette\}, \{Stephanie K.\} and Chau, \{Nicole G.\} and Guilherme Rabinowits and Lorch, \{Jochen H.\} and Haddad, \{Robert I.\} and Tishler, \{Roy B.\} and Anderson, \{Karen S.\} and Schoenfeld, \{Jonathan D.\}",

note = "BACKGROUND: HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) is increasing in incidence. Laboratory assays that identify virally-mediated disease and predict HPV clearance in OPSCC may have important prognostic implications. OBJECTIVE: He",

year = "2017",

month = jun,

day = "23",

doi = "10.3233/CBM-160071",

language = "American English",

volume = "19",

journal = "Cancer Biomarkers",

}

TY - JOUR

T1 - Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma

AU - Hanna, Glenn J.

AU - Sridharan, Vishwajith

AU - Margalit, Danielle N.

AU - La Follette, Stephanie K.

AU - Chau, Nicole G.

AU - Rabinowits, Guilherme

AU - Lorch, Jochen H.

AU - Haddad, Robert I.

AU - Tishler, Roy B.

AU - Anderson, Karen S.

AU - Schoenfeld, Jonathan D.

N1 - BACKGROUND: HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) is increasing in incidence. Laboratory assays that identify virally-mediated disease and predict HPV clearance in OPSCC may have important prognostic implications. OBJECTIVE: He

PY - 2017/6/23

Y1 - 2017/6/23

UR - https://content.iospress.com/articles/cancer-biomarkers/cbm160071

U2 - 10.3233/CBM-160071

DO - 10.3233/CBM-160071

M3 - Article

VL - 19

JO - Cancer Biomarkers

JF - Cancer Biomarkers

ER -

Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma

Disciplines

Access to Document

Other files and links

Cite this